#1 Clinical Trials Search in Europe

Oxybutynin

Oxybutynin is a medication commonly used in clinical trials to treat overactive bladder and related urinary conditions. These trials explore different formulations, dosages, and applications of oxybutynin to evaluate its effectiveness and safety in various patient populations, including children and adults with neurological conditions affecting bladder function.

Table of Contents

What is Oxybutynin?

Oxybutynin is a medication primarily used to treat various bladder and urinary conditions. It belongs to a class of drugs called anticholinergics, which work by relaxing the muscles in the bladder. Oxybutynin is known by several brand names, including Ditropan, Ditropan XL, and Oxytrol[1]. It’s available in different forms, such as tablets, extended-release tablets, syrup, and transdermal patches (applied to the skin)[1][4].

Conditions Treated by Oxybutynin

Oxybutynin is used to treat several conditions related to bladder and urinary function:

  • Overactive Bladder (OAB): This condition is characterized by frequent urination, urgency (sudden, strong need to urinate), and sometimes urge incontinence (leaking urine)[4].
  • Neurogenic Bladder: This is a condition where the bladder doesn’t function properly due to a neurological problem, such as spina bifida[1][5].
  • Detrusor Hyperreflexia: This is a condition where the bladder muscle (detrusor) contracts involuntarily, leading to frequent urination and possible incontinence[1].
  • Nocturnal Enuresis: Also known as bedwetting, this condition is common in children and can sometimes be treated with oxybutynin[10].
  • Mixed Urinary Incontinence: This involves both stress incontinence (leaking urine during physical activities) and urge incontinence[2].

How Oxybutynin Works

Oxybutynin works by relaxing the muscles in the bladder. It does this by blocking certain nerve signals that cause the bladder muscles to contract. By relaxing these muscles, oxybutynin can help reduce symptoms such as frequent urination, urgency, and incontinence[1][4].

Forms and Administration

Oxybutynin comes in several forms:

  • Oral tablets: These are typically taken 2-3 times daily[1].
  • Extended-release tablets: These are usually taken once daily[1].
  • Syrup: This liquid form can be helpful for children or those who have difficulty swallowing tablets[1].
  • Transdermal patch: This is a patch applied to the skin that delivers the medication continuously. It’s typically changed every 3-4 days[4].
  • Topical gel: This is applied to the skin daily[9].

The dosage and form of oxybutynin prescribed will depend on the patient’s age, condition, and response to treatment[1][4].

Effectiveness of Oxybutynin

Clinical trials have shown that oxybutynin can be effective in treating various bladder conditions. Some key findings include:

  • Increased bladder capacity: Oxybutynin has been shown to increase the average volume of urine that the bladder can hold before needing to be emptied[1].
  • Reduced incontinence episodes: Many patients experience fewer episodes of urine leakage when using oxybutynin[1][2].
  • Improved quality of life: By reducing urinary symptoms, oxybutynin can significantly improve patients’ quality of life[2].

Side Effects and Precautions

Like all medications, oxybutynin can cause side effects. Common side effects include:

  • Dry mouth: This is one of the most common side effects[8].
  • Constipation: Oxybutynin can slow down bowel movements[8].
  • Blurred vision: This can occur temporarily[10].
  • Drowsiness or dizziness: These effects can occur, especially when starting the medication[4].
  • Skin reactions: When using the transdermal patch, some people may experience skin irritation at the application site[4].

It’s important to discuss any side effects with your healthcare provider. They may be able to adjust your dosage or suggest ways to manage side effects[4].

Special Considerations

There are some special considerations to keep in mind when using oxybutynin:

  • Use in children: Oxybutynin can be used in children with certain bladder conditions, but the dosage and form may differ from adult use[1][9].
  • Heat exposure: When using the transdermal patch or gel form of oxybutynin, exposure to heat (such as during exercise or in hot weather) may increase the amount of medication absorbed by the body. This could potentially increase side effects[6].
  • Long-term use: Some studies have looked at the long-term use of oxybutynin, including its use for conditions like hyperhidrosis (excessive sweating)[8].
  • Combination therapy: In some cases, oxybutynin may be used in combination with other treatments, such as behavioral therapy or surgical interventions, for optimal management of bladder conditions[2].

Always follow your healthcare provider’s instructions when taking oxybutynin, and don’t hesitate to ask questions or report any concerns you may have about your treatment.

Aspect Details
Primary Conditions Studied Overactive bladder, detrusor hyperreflexia, urge urinary incontinence, neurogenic bladder
Formulations Tested Oral tablets, transdermal patches, topical gels, intravaginal administration
Patient Populations Adults and children, including those with neurological conditions
Key Outcome Measures Urinary frequency, urgency, incontinence episodes, catheterization volumes, quality of life
Side Effects Monitored Dry mouth, constipation, blurred vision, skin reactions (for transdermal applications)
Special Focus Areas Pediatric dosing, comparison of different formulations, biomarker studies

FAQ

  • What conditions is oxybutynin used to treat in these clinical trials? Oxybutynin is primarily used to treat overactive bladder syndrome, detrusor hyperreflexia, urge urinary incontinence, and neurogenic bladder in these trials. It's also being studied for nocturnal enuresis in children.
  • What are the different forms of oxybutynin being tested? The trials are testing various forms of oxybutynin, including oral tablets, transdermal patches, topical gels, and intravaginal administration. Each form has potential benefits in terms of efficacy and side effect profiles.
  • Are there any trials specifically for children? Yes, several trials focus on pediatric patients. These include studies on children with neurogenic bladder, overactive bladder, and nocturnal enuresis. The trials aim to determine safe and effective dosages for children of different ages.
  • What are some of the main outcomes being measured in these trials? Common outcomes include changes in urinary frequency, urgency, incontinence episodes, catheterization volumes, and quality of life measures. Some trials also look at specific urodynamic parameters and the presence of urinary biomarkers.
  • Are there any notable side effects of oxybutynin being studied? Side effects being monitored include dry mouth, constipation, blurred vision, and skin reactions for transdermal applications. Some trials are specifically designed to compare the side effect profiles of different formulations of oxybutynin.

Ongoing Clinical Trials on Oxybutynin

  • Study on Early Oxybutynin Treatment for Boys with Posterior Urethral Valves

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Oxybutynin and Venlafaxine for Reducing Hot Flashes in Women Undergoing Endocrine Therapy After Breast Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Overactive Bladder (OAB): A condition characterized by sudden urges to urinate that may be difficult to control, often accompanied by frequent urination and nocturia (nighttime urination).
  • Detrusor Hyperreflexia: A condition where the bladder muscle (detrusor) contracts involuntarily, often due to neurological issues, leading to frequent and urgent urination.
  • Neurogenic Bladder: A dysfunction of the urinary bladder due to disease of the central nervous system or peripheral nerves involved in the control of urination.
  • Urodynamic Study: A test that assesses how well the bladder, sphincters, and urethra are storing and releasing urine.
  • Transdermal: A route of administration where the drug is delivered across the skin for systemic distribution.
  • Anticholinergic: A type of medication that blocks the neurotransmitter acetylcholine in the nervous system, often used to treat overactive bladder.
  • Bioavailability: The proportion of a drug or other substance which enters the circulation when introduced into the body and so is able to have an active effect.
  • Nocturnal Enuresis: Involuntary urination that occurs at night during sleep, commonly known as bedwetting.

References

  1. https://clinicaltrials.gov/study/NCT00224016
  2. https://clinicaltrials.gov/study/NCT01899794
  3. https://clinicaltrials.gov/study/NCT00749632
  4. https://clinicaltrials.gov/study/NCT04534491
  5. https://clinicaltrials.gov/study/NCT03952299
  6. https://clinicaltrials.gov/study/NCT03205605
  7. https://clinicaltrials.gov/study/NCT02704013
  8. https://clinicaltrials.gov/study/NCT01956591
  9. https://clinicaltrials.gov/study/NCT01192568
  10. https://clinicaltrials.gov/study/NCT02538302